Clinical Trial Update: Semaglutide Treatment On Coronary Progression [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating semaglutide treatment on coronary progression in patients with Type 2 Diabetes and Coronary Artery Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Type 2 Diabetes, Coronary Artery Disease | Phase 4 | Status: COMPLETED